COVID-19 Drug design and Development
COVID-19 medicate advancement is the inquire about handle to create preventative helpful medicine drugs that would reduce the seriousness of coronavirus illness 2019 (COVID-19). From early 2020 through 2021, a few hundred medicate companies, biotechnology firms, college investigate bunches, and wellbeing organizations were creating restorative candidates for COVID-19 infection in different stages of preclinical or clinical investigate (506 add up to candidates in April 2021), with 419 potential COVID-19 drugs in clinical trials, as of April 2021.
Related Conference of COVID-19 Drug design and Development
August 21-22, 2024
5th International conference on Vaccines, Vaccination and Immunization
Paris, France
September 12-13, 2024
19th International Conference on Allergy and Clinical Immunology
Paris, France
October 24-25, 2024
5th International Conference on Immunology And Immunotherapy
Zurich, Switzerland
COVID-19 Drug design and Development Conference Speakers
Recommended Sessions
- Cardiac manifestations of coronavirus
- Coronaviruses (COVID-19)
- COVID-19 and Environmental Health
- COVID-19 Clinical Trails
- COVID-19 Drug design and Development
- Epidemiological Characteristics of COVID-19
- Food and Nutrition
- Genomics and transmissibility
- Infectious Diseases Covid-19
- Mental health
- Monoclonal antibody treatments
- Omicron
- SARS-CoV-2 variants
- Severe Acute Respiratory Syndrome Coronavirus 2
- Therapeutics and COVID-19
- Vaccines
- Virology
Related Journals
Are you interested in
- Advances in Molecular Immunology - ALLERGY 2024 (France)
- Allergen Identification and Characterization - ALLERGY 2024 (France)
- Biomarkers for Allergy Diagnosis and Treatment - ALLERGY 2024 (France)
- Cancer Immunology and Immunotherapy - IMMUNOLOGY 2024 (Spain)
- Case Studies in Allergy Diagnosis and Management - ALLERGY 2024 (France)
- Cell & Plant Biology - IMMUNOLOGY 2024 (Spain)
- Cell Biology - IMMUNOLOGY 2024 (Spain)
- CELL, ANIMAL & PLANT BIOLOGY - IMMUNOLOGY 2024 (Spain)
- Clinical Immunology & Current & Future Research - IMMUNOLOGY 2024 (Spain)
- Clinical Trials and Translational Research in Allergy and Immunology - ALLERGY 2024 (France)
- Digital Health and Telemedicine in Allergy Care - ALLERGY 2024 (France)
- Epidemiology and Population Studies in Allergic Diseases - ALLERGY 2024 (France)
- Immune Responses to Vaccination - ALLERGY 2024 (France)
- Immune System - IMMUNOLOGY 2024 (Spain)
- Immuno informatics & Systems immunology - IMMUNOLOGY 2024 (Spain)
- Immuno-Genetics - IMMUNOLOGY 2024 (Spain)
- Immunogenetics - IMMUNOLOGY 2024 (Spain)
- Immunogenetics and Allergic Susceptibility - ALLERGY 2024 (France)
- Immunohistochemistry - IMMUNOLOGY 2024 (Spain)
- Immunological Aspects of Drug Allergies - ALLERGY 2024 (France)
- Immunological Basis of Food Allergy - ALLERGY 2024 (France)
- Immunological Mechanisms in Autoimmune Diseases - ALLERGY 2024 (France)
- Immunology - IMMUNOLOGY 2024 (Spain)
- Immunomodulation in Allergy Management - ALLERGY 2024 (France)
- Immunopathogenesis of Allergic Diseases - ALLERGY 2024 (France)
- Immunotherapy - IMMUNOLOGY 2024 (Spain)
- Immunotherapy for Allergic Conditions - ALLERGY 2024 (France)
- Inflammatory Pathways in Asthma and Allergic Rhinitis - ALLERGY 2024 (France)
- Mechanisms of Immunodeficiency Diseases - ALLERGY 2024 (France)
- Novel Therapeutic Approaches for Allergic Disorders - ALLERGY 2024 (France)
- Nutritional Immunology - IMMUNOLOGY 2024 (Spain)
- OncoImmunology - IMMUNOLOGY 2024 (Spain)
- Pediatric and Neonatal Immunology - IMMUNOLOGY 2024 (Spain)
- Reproductive Immunology - IMMUNOLOGY 2024 (Spain)
- Role of Microbiota in Allergic Disorders - ALLERGY 2024 (France)
- Transplantation and Computational Immunology - IMMUNOLOGY 2024 (Spain)
- Vaccines & Immunization - IMMUNOLOGY 2024 (Spain)
- Virology and infectious diseases - IMMUNOLOGY 2024 (Spain)